コーパス検索結果 (1語後でソート)
  通し番号をクリックするとPubMedの該当ページを表示します
  
   1 on-gamma (IFN-gamma), generally considered a proinflammatory cytokine.                               
     2 ractant, whereas a disulfide bond makes it a proinflammatory cytokine.                               
     3 n of the thymic stromal lymphopoietin (TSLP) proinflammatory cytokine.                               
     4 K signalling and increases the production of proinflammatory cytokines.                              
     5 d profound uveal inflammation and release of proinflammatory cytokines.                              
     6 related with enhanced expression of numerous proinflammatory cytokines.                              
     7 ecific T cell proliferation and secretion of proinflammatory cytokines.                              
     8 duced by macrophages induces upregulation of proinflammatory cytokines.                              
     9  infection in response to local cDC1-derived proinflammatory cytokines.                              
    10 ry smooth cells secrete IL-26 in response to proinflammatory cytokines.                              
    11 ied regarding the induction of Th2, Th1, and proinflammatory cytokines.                              
    12 eta activation that upregulates secretion of proinflammatory cytokines.                              
    13 ment of inflammatory cells and production of proinflammatory cytokines.                              
    14 e into effector T cells capable of producing proinflammatory cytokines.                              
    15 having highly elevated levels of circulating proinflammatory cytokines.                              
    16  markers of illness, and local production of proinflammatory cytokines.                              
    17 ing plasmablasts in the presence of BAFF and proinflammatory cytokines.                              
    18 n relation to the mRNA expression profile of proinflammatory cytokines.                              
    19  that prevent phagocytosis and generation of proinflammatory cytokines.                              
    20  a regulatory phenotype in vitro and secrete proinflammatory cytokines.                              
    21  the mechanisms behind its downregulation by proinflammatory cytokines.                              
    22 sult in aberrations in production of various proinflammatory cytokines.                              
    23 s increase production of numerous additional proinflammatory cytokines.                              
    24  microbial products through the synthesis of proinflammatory cytokines.                              
    25 h17 cells, and produced increased amounts of proinflammatory cytokines.                              
    26 endogenous CLIP170 potentiated the levels of proinflammatory cytokines.                              
    27 LPS and promotes pyroptosis and secretion of proinflammatory cytokines.                              
    28 se two signals cause the release of multiple proinflammatory cytokines.                              
    29 lls promote IR, in part through secretion of proinflammatory cytokines.                              
    30 osis factor (TNF) but had no effect on other proinflammatory cytokines.                              
    31 ting levels of CXCL9, CXCL10, and downstream proinflammatory cytokines.                              
    32  CD8(+) cells, alanine aminotransferase, and proinflammatory cytokines.                              
    33  CD200R expression produced higher levels of proinflammatory cytokines.                              
    34 on of T cell responses and the production of proinflammatory cytokines.                              
    35 nt expression of type I interferon and other proinflammatory cytokines.                              
    36  in increased production of type 2 and other proinflammatory cytokines.                              
    37 ncluding Kupffer cells exposed to HCV induce proinflammatory cytokines.                              
    38 signaling pathways leading to the release of proinflammatory cytokines.                              
    39 -M, also known as IRAK-3, is an inhibitor of proinflammatory cytokine and chemokine expression in int
  
    41  IFNs but were associated with altered local proinflammatory cytokine and chemokine responses and dif
    42 indings indicate that S100A12 functions as a proinflammatory cytokine and suggest that S100A12 is a p
  
    44 antagonists of GHRH suppressed the levels of proinflammatory cytokines and altered the expression of 
    45 in and bryostatin-1 induce secretion of some proinflammatory cytokines and an increase of ICAM-1 expr
    46  RA101295 abolished sepsis-induced surges in proinflammatory cytokines and attenuated systemic circul
    47 t SCARF-1 expression by HSEC is regulated by proinflammatory cytokines and bacterial lipopolysacchari
  
  
    50 ction significantly increasing the levels of proinflammatory cytokines and chemokines in the M1 versu
    51 ted chemokine concurrent with an increase in proinflammatory cytokines and chemokines were seen after
    52 Gal-3 treatment was accompanied by increased proinflammatory cytokines and chemokines within the loca
    53 stable proliferation arrest and secretion of proinflammatory cytokines and chemokines, the senescence
  
  
  
  
    58 very to the lung downregulates expression of proinflammatory cytokines and improves allergen-induced 
    59    Activation of Nlrp3 leads to synthesis of proinflammatory cytokines and influences epithelial inte
    60 hese macrophage-like nanoparticles sequester proinflammatory cytokines and inhibit their ability to p
    61 of infection, WT mice had higher circulatory proinflammatory cytokines and lower anti-inflammatory cy
  
    63 NA expression as well as expression of other proinflammatory cytokines and mediators, including IL-1a
    64 -cycle arrest combined with the secretion of proinflammatory cytokines and mitochondrial dysfunction.
    65 duced sepsis, decreases the plasma levels of proinflammatory cytokines and organ injury markers in a 
    66 f atherosclerotic plaques, the production of proinflammatory cytokines and reactive oxygen species, t
    67 e precipitating steps involve the release of proinflammatory cytokines and stress hormones, increased
    68 glucocorticoid biosynthesis is suppressed by proinflammatory cytokines and that glucocorticoid defici
    69 that BCA2 is induced by NF-kappaB-activating proinflammatory cytokines and that upregulation of BCA2 
    70 unity by changing the homeostatic balance of proinflammatory cytokines and the human immune system, i
    71 urified sLRP1 induced expression of multiple proinflammatory cytokines and the mRNA encoding inducibl
    72 mulated insulin secretion in the presence of proinflammatory cytokines and triggered gene expression 
    73 tion, and leukocyte migration plus genes for proinflammatory cytokines and various toll-like receptor
    74 rentiation-associated genes, upregulation of proinflammatory cytokines, and accumulation of Langerhan
    75 roteins, leading to increased levels of ROS, proinflammatory cytokines, and adhesion molecules in SCD
    76 binding to TLR2 induced robust expression of proinflammatory cytokines, and end products of lipid oxi
    77 emlin1 and R-spondin1 as well as chemokines, proinflammatory cytokines, and growth factors with key r
    78 beta cells resistant to apoptosis induced by proinflammatory cytokines, and inhibition of autophagy w
    79 reatment showed decreased mRNA expression of proinflammatory cytokines, and partially reversed TNF-al
    80 traumatic insult), become activated, produce proinflammatory cytokines, and recruit monocytes and den
    81  inflammatory cells with local production of proinflammatory cytokines, and subsequent epithelial dis
  
    83 mmation, accompanied by a massive release of proinflammatory cytokines at the maternal-fetal interfac
    84 ion is associated with intense production of proinflammatory cytokines, but whether this cytokine sto
    85 ens at various nonmucosal sites by eliciting proinflammatory cytokines by human macrophages, monocyte
    86  these glycolipids induced the production of proinflammatory cytokines by macrophages, thereby sugges
  
    88 (less cardiac infiltrates and suppression of proinflammatory cytokines), cardiac fibrosis, apoptosis,
    89 l inflammation by inducing the expression of proinflammatory cytokines, chemokines and matrix metallo
    90 mote pathophysiologic developments involving proinflammatory cytokines, chemokines, and adhesion mole
    91 ation of many antiviral molecules, including proinflammatory cytokines, chemokines, and IFN-stimulate
    92 ases 1 (TIMP-1), downregulated expression of proinflammatory cytokines/chemokines, and significantly 
    93  survival and decreased alveolar protein and proinflammatory cytokine concentrations, whereas increas
    94 ninfected, TT-genotype patients had high CSF proinflammatory cytokine concentrations, with intermedia
    95     Interferon gamma (IFNgamma) is the major proinflammatory cytokine conferring resistance to the in
    96 tion of inflammation, including reduction of proinflammatory cytokines (CXCL1, CXCL2, CCL3, CCL4, IL6
  
    98 on of TNF-alpha and IL-1beta, widely studied proinflammatory cytokines, did not induce persistent dis
  
   100 ungs and their relationship with circulating proinflammatory cytokines during ischemia-reperfusion in
  
   102 also reduces chemotherapy-induced release of proinflammatory cytokines (e.g., TNFalpha), hypertrophic
   103 phate nucleotidohydrolase induced SAMHD1 and proinflammatory cytokines (eg, interleukin 6, interleuki
  
   105  Csn5 KO potentiated NF-kappaB signaling and proinflammatory cytokine expression in macrophages, wher
   106 ed a mechanism by which Muller cells trigger proinflammatory cytokine expression in myeloid cells.   
   107 mediated induction of adhesion molecules and proinflammatory cytokine expression in response to LPS. 
  
  
   110 tion, with increased histological scores and proinflammatory cytokine expression, compared to control
  
  
   113 phages results in the coordinated release of proinflammatory cytokines, followed by regulatory mediat
   114 o, these dendrimers reduced the secretion of proinflammatory cytokines from mice and human monocyte-d
  
   116 nza virus-induced lethality and reduced both proinflammatory cytokine gene expression in the lungs an
   117 7- to 2.1-fold increase in levels of several proinflammatory cytokines (GM-CSF, IFN-gamma, IL-1beta, 
   118 ng a mouse model of colitis, we identify the proinflammatory cytokine granulocyte-colony-stimulating 
  
  
   121 r cytotoxic mediators (perforin/granzyme B), proinflammatory cytokines (IFNgamma/TNFalpha), and expre
  
   123  nonrelevant modifications of the prototypic proinflammatory cytokine IL-1beta during an immune respo
   124 iated with reduced microglial activation and proinflammatory cytokine IL-1beta within the subfornical
  
  
   127 ated the canonical NF-kappaB pathway and the proinflammatory cytokine IL-6 in autoantibody production
   128 naling potently repressed the release of the proinflammatory cytokine IL-6 in primary mouse HD and WT
  
  
   131 , NRF2 induction repressed expression of the proinflammatory cytokines IL-1, IL-6, IL-8, and TNFalpha
   132 f caspase-1 leading to the maturation of the proinflammatory cytokines IL-1beta and IL-18 and promoti
   133 ensified NLRP3 activation, overproduction of proinflammatory cytokines IL-1beta and IL-18, and increa
  
  
   136 y suppress the production of the ILC2-driven proinflammatory cytokines IL-5 and IL-13 both in vitro a
   137 R4 activation to limit the production of the proinflammatory cytokines IL-6 and IL-12p40 while enhanc
   138  associated with decreased concentrations of proinflammatory cytokines (IL-1alpha, IL-8, IL-12(p70)) 
  
   140 he incident visit and when concentrations of proinflammatory cytokines (IL-1beta, IL-12p70) were incr
   141 ce exhibited significantly reduced levels of proinflammatory cytokines (IL-4, IL-5, and IL-13) and de
   142 from ER stress - apoptosis, NF-kappaB (p65), proinflammatory cytokines (IL-6, IL-1beta), neutrophil c
   143 dicate that FP7 antagonized the secretion of proinflammatory cytokines (IL-6, IL-8, and MIP-1beta) by
  
   145 emia was shown to promote gene expression of proinflammatory cytokines (il1beta, il6, il8, and tnfalp
   146 25-3p and miR-92a-3p stimulated secretion of proinflammatory cytokine IL6 from tumor-associated macro
  
   148    The mRNA and protein expression levels of proinflammatory cytokines IL6, IL8 and CCL5 were determi
  
  
  
  
   153 ice showed exacerbated lung inflammation and proinflammatory cytokines in an ozone-exposure model.   
   154 ased survival rates and heightened levels of proinflammatory cytokines in both peritoneal lavage and 
  
   156 te-phase proteins, inflammatory markers, and proinflammatory cytokines in individuals with (infected 
   157  was more strongly induced by stimulation of proinflammatory cytokines in keratinocytes and fibroblas
  
   159 he reduced capacity of leukocytes to release proinflammatory cytokines in response to ex vivo stimula
  
   161 d mononuclear cells (MMCs) and the levels of proinflammatory cytokines in the blood and the brains of
  
   163 ce of immune complexes and the production of proinflammatory cytokines in the kidneys and normal humo
   164 -alpha and IL-1beta induced transcription of proinflammatory cytokines in the primary synoviocytes.  
   165 ned the effect of NRTIs on the expression of proinflammatory cytokines in the various CNS regions.   
  
  
   168 k of suppression of cytotoxic mediators, and proinflammatory cytokines, in peripheral blood T, NKT-li
   169 in impaired induction of a broad spectrum of proinflammatory cytokines, including IL-1, IL-36, and th
   170 , P2X7R activation induces the production of proinflammatory cytokines, including IL-1beta and IL-18,
   171 crobial and stress products to activation of proinflammatory cytokines, including IL-1beta The potent
   172 istently resulted in increased production of proinflammatory cytokines, including iNOS, TNF-alpha, an
   173  the dysregulation of osteoclast activity by proinflammatory cytokines, including TNF, interferes wit
   174 tivation characterized by elevated levels of proinflammatory cytokines, including type I interferons 
  
   176 ar pattern by counteracting the synthesis of proinflammatory cytokines, inhibiting neutrophil traffic
  
  
  
  
   181 tivation, inducing maturation and release of proinflammatory cytokine interleukin-1beta (IL-1beta) an
   182 ome promotes caspase-1-mediated secretion of proinflammatory cytokines interleukin (IL)-1beta and IL-
   183 e Langerhans cell chemoattractant CCL20, and proinflammatory cytokines interleukin 1alpha (IL-1alpha)
   184 , and quantitative RT-PCR (qRT-PCR), and the proinflammatory cytokines interleukin 1beta, interferon 
   185 T cells have emerged as major sources of the proinflammatory cytokines interleukin-17 (IL-17) and int
   186 dent subjects compared with controls for the proinflammatory cytokines interleukin-6 and interleukin-
   187 ntigen 4, anti-programmed death ligand 1) or proinflammatory cytokines (interleukin [IL] 12) were use
   188 C-treated hearts show enhanced production of proinflammatory cytokines (interleukin-3, interleukin-6,
   189  1 [MMP-1] and heme oxygenase 1 [HO-1]), and proinflammatory cytokines (interleukin-6 [IL-6], IL-8, m
  
  
   192 There were corresponding increased levels of proinflammatory cytokines KC (P = .0001) and IL-6 (P = .
  
   194 educed islet interleukin-1beta expression, a proinflammatory cytokine known to stimulate prostaglandi
   195 e microglia could be ineffective and produce proinflammatory cytokines leading to progressive neurona
   196 influx of astrocytes and microglia releasing proinflammatory cytokines leads to dramatic inflammation
   197 ess-induced elevations in corticosterone and proinflammatory cytokine levels and depression-like and 
   198 duced inflammation, as measured by decreased proinflammatory cytokine levels and neutrophil recruitme
  
   200  decreased joint inflammation, swelling, and proinflammatory cytokine levels relative to WT mice.    
  
   202 king nanoparticles, termed MPhi-NPs, reduced proinflammatory cytokine levels, inhibited bacterial dis
   203 at wild type mice had significantly elevated proinflammatory cytokine levels, reduced ejection fracti
  
   205 ing and cellular activation by virus-induced proinflammatory cytokines like tumor necrosis factor and
   206  with pH1N1/NSs-6mut induced lower levels of proinflammatory cytokines, likely due to a general inhib
  
  
   209 xpression of the proapoptotic factor Bim and proinflammatory cytokines MCP-1, IL-6, and E-selectin.  
  
   211 r (NF)-kappaB, which induced expression of a proinflammatory cytokine module that, along with the ant
  
   213 ifibrotic activity and reduced production of proinflammatory cytokines most likely by activation of t
  
   215 A-sequencing analysis showed upregulation of proinflammatory cytokines, NF-kappaB signaling, and heat
  
   217 ht bacterial infection, heightened levels of proinflammatory cytokines, overt granulocyte/monocyte pr
  
  
  
   221 iologics are currently available that target proinflammatory cytokines produced by T lymphocytes, but
   222 heir ability to make IL-17, were more potent proinflammatory cytokine producers, and were powerful in
  
  
   225 ific PRMT1 knock-out mice demonstrate higher proinflammatory cytokine production and a lower survival
   226 ng trauma but displayed decreased stimulated proinflammatory cytokine production and significantly re
   227 d survival, attenuated hypothermia, and less proinflammatory cytokine production during septic shock 
   228 S stimulated NF-kappaB activation and caused proinflammatory cytokine production in alveolar macropha
   229  of Fas-mediated apoptosis and its effect on proinflammatory cytokine production in early alcoholic l
   230      RGS10 has emerged as a key regulator of proinflammatory cytokine production in microglia, functi
  
   232 cally re-establishes normal homeostasis, and proinflammatory cytokine production returns to baseline.
  
   234 ent mice indicated that Acanthamoeba-induced proinflammatory cytokine production was through MyD88-de
   235 these mice displayed enhanced proliferation, proinflammatory cytokine production, and effector molecu
   236 mmaT and suppressing Th17 lineage stability, proinflammatory cytokine production, and pathogenicity. 
   237 successfully dampened PMA-induced ear edema, proinflammatory cytokine production, reactive oxygen and
  
  
  
  
  
  
   244  represents an efficacious and, based on its proinflammatory cytokine profile, targeted treatment opt
   245 C) significantly reduced plasma LPS-elicited proinflammatory cytokines, reflecting endotoxin toleranc
   246 ulum of tumor cells by triggering macrophage proinflammatory cytokine release after phosphatidylserin
   247 downregulated markers of toxicity, including proinflammatory cytokine release and cellular proliferat
  
  
   250 l4/del4) cholangiocytes, in turn, respond to proinflammatory cytokines released by macrophages by up-
  
  
   253 in D3 resulted in an enhanced broad-spectrum proinflammatory cytokine response of cord blood mononucl
   254 , and expansion of blood monocytes with less proinflammatory cytokine response to bacterial stimulati
   255   Furthermore, BCD attenuated the CC-induced proinflammatory cytokine responses (e.g., IL-1alpha, MIP
   256 ntrolling parasite burden by contributing to proinflammatory cytokine responses by DCs and natural ki
   257  interferon (IFN), IFN-stimulating gene, and proinflammatory cytokine responses in Mavs(-/-) dendriti
   258 ges (pH1N1/NSs-6mut) induced lower levels of proinflammatory cytokines, resulting in viral attenuatio
   259 nhancement of cryptic peptides was caused by proinflammatory cytokines, secreted in response to micro
   260 e, IL-26 allows extracellular DNA to trigger proinflammatory cytokine secretion by monocytes, in a ST
   261 on of epithelial integrity, and induction of proinflammatory cytokine secretion by S. Paratyphi A but
  
   263 e degrading desmosomal proteins and inducing proinflammatory cytokine secretion through protease-acti
   264 66b(bright), CD63(bright) surface phenotype, proinflammatory cytokine secretion, and cytotoxicity.   
   265 FlaA:Betv1-mediated IL-10 secretion, but not proinflammatory cytokine secretion, was inhibited by rap
   266 y through a mechanism dependent on NF-kappaB proinflammatory cytokine signaling pathway in both norma
   267 F-kappaB activation following treatment with proinflammatory cytokines, specifically interleukin-1bet
   268 erived from donor lungs, and not circulating proinflammatory cytokines substantially impaired the qua
   269 cer cells in vitro induced the expression of proinflammatory cytokines such as CXCL5 by activating St
  
   271 1/IRAK-4-mediated signaling and secretion of proinflammatory cytokines such as IL-12, IL-6, or TNF-al
   272 stitutive proteasomes after cell exposure to proinflammatory cytokines such as interferon-gamma.     
   273 exposure showed decreased gene expression of proinflammatory cytokines such as tumor necrosis factor-
   274 gnificantly higher expression and release of proinflammatory cytokines, such as chemokine (C-C motif)
   275 ctivation of caspase-1 and the maturation of proinflammatory cytokines, such as IL-1beta and IL-18.  
   276 ates inflammation by degrading mRNA encoding proinflammatory cytokines, such as IL6, IL1, and IL12.  
   277 +) monocytes, as well as increased levels of proinflammatory cytokines, such as TNF-alpha and IL-17. 
   278 ading to cell type-specific amplification of proinflammatory cytokines, such as TNF-alpha, IL-1beta, 
   279 h covR-deficient S. agalactiae produced less proinflammatory cytokines than those infected with wild-
  
   281 eptor (TLR) 4, which leads to the release of proinflammatory cytokines that are essential for a poten
   282 eptor-modified T cells (CAR T cells) produce proinflammatory cytokines that increase expression of T-
   283 nalysis of human macrophages showed that the proinflammatory cytokines TNF and type I interferons ind
  
   285 ition, CD70(-/-) hosts have higher levels of proinflammatory cytokines TNF-alpha, IFN-gamma, IL-2, an
   286 atory protein cyclooxygenase (COX)-2 and the proinflammatory cytokines TNF-alpha, IL-6, and IL-12.   
   287 In this work, we titered bacteria and/or the proinflammatory cytokine TNFalpha in a set of establishe
  
   289 utes to their extraordinary vulnerability to proinflammatory cytokine toxicity and may therefore repr
   290 ular barrier was impaired by Ca2+ depletion, proinflammatory cytokine tumor necrosis factor alpha, or
   291 inked to the expression of the M1-associated proinflammatory cytokine tumor necrosis factor, inducibl
   292  microglia in the ARC, the expression of the proinflammatory cytokine tumor necrosis factor-alpha in 
   293  Kal directly activated monocytes to produce proinflammatory cytokines, up-regulated their C5aR and F
   294 oxin preconditioning reduced serum levels of proinflammatory cytokines, upregulated molecular pathway
   295 ults together suggest that NRTIs up-regulate proinflammatory cytokines via a Wnt5a signaling-dependen
  
   297  in Ld-infected cells curtails production of proinflammatory cytokines, which are otherwise detriment
   298 itantly, S. aureus elicits the production of proinflammatory cytokines, which could ultimately pertur
   299 s significant inhibition in the synthesis of proinflammatory cytokines with a concordant blockade of 
  
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。